Lytix Biopharma: Invitation to presentation of first quarter 2024 results, Thursday 30 May 2024
Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company, will release its first quarter 2024 results on Thursday, 30 May 2024. The results will be presented in a webcast with CEO Øystein Rekdal and CFO Gjest Breistein at 1:00pm CET. We encourage you to send us questions in advance, to be addressed during the Q&A session. Please send your questions in an email to post@lytixbiopharma.com. The presentation and subsequent Q&A session will be held in English and may be viewed live by registering here: https://forms.office.com/e/0djcLzR8Za